Nic G. Scalfarotto
Geen lopende functies
Profiel
Nic G.
Scalfarotto is former Senior Vice President-Regulatory Affairs at Kura Oncology, Inc., former VP-Regulatory Affairs & Program Management at X4 Pharmaceuticals, Inc., former Vice President-Regulatory Affairs for Momenta Pharmaceuticals, Inc. and former Senior Vice President-Regulatory Affairs at Aegerion Pharmaceuticals, Inc.
Nic G.
Scalfarotto received a doctorate from Alma Mater Studiorum - Università di Bologna and an undergraduate degree from Seton Hall University.
Eerdere bekende functies van Nic G. Scalfarotto
Bedrijven | Functie | Einde |
---|---|---|
KURA ONCOLOGY, INC. | General Counsel | - |
X4 PHARMACEUTICALS, INC. | General Counsel | - |
AEGERION PHARMACEUTICALS, INC. | General Counsel | - |
MOMENTA PHARMACEUTICALS, INC. | General Counsel | - |
Opleiding van Nic G. Scalfarotto
Seton Hall University | Undergraduate Degree |
Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
KURA ONCOLOGY, INC. | Health Technology |
X4 PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |